Published in Hepatology on November 01, 1997
Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg (1999) 4.97
The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg (2005) 3.46
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw (2009) 3.25
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92
The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut (2005) 2.82
A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg (2004) 2.20
Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg (2003) 2.00
Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg (2010) 1.81
Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg (2006) 1.76
Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg (2008) 1.60
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) (2010) 1.59
Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2013) 1.50
Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy. J Gastroenterol (2006) 1.48
Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg (2002) 1.45
Preoperative portal vein embolization in liver cancer: indications, techniques and outcomes. Quant Imaging Med Surg (2015) 1.42
High risk of biliary fistula after isolated segment VIII liver resection. World J Surg (2012) 1.40
Impact of preoperative planning using virtual segmental volumetry on liver resection for hepatocellular carcinoma. World J Surg (2007) 1.35
Current surgical treatment for bile duct cancer. World J Gastroenterol (2007) 1.30
Portal hypertension: contraindication to liver surgery? World J Surg (2006) 1.18
Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg (2012) 1.17
Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol (2012) 1.15
Hepatocellular carcinoma: natural history, current management, and emerging tools. Biologics (2012) 1.10
Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol (2013) 1.08
A worldwide survey of the current daily practice in liver surgery. Liver Cancer (2013) 1.04
Liver failure following partial hepatectomy. HPB (Oxford) (2006) 1.03
Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg (2012) 1.02
Standardized liver volumetry for portal vein embolization. Semin Intervent Radiol (2008) 1.01
Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan((R))) before curative resection of hepatocellular carcinoma: a pilot study. Hepatol Int (2008) 1.00
Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique. Ann Surg Oncol (2010) 0.95
Quality improvement for portal vein embolization. Cardiovasc Intervent Radiol (2010) 0.93
Hepatocellular carcinoma--resection or transplant? Nat Rev Gastroenterol Hepatol (2012) 0.92
Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol (2011) 0.92
Volumetric and functional recovery of the remnant liver after major liver resection with prior portal vein embolization : recovery after PVE and liver resection. J Gastrointest Surg (2009) 0.92
Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics. J Gastroenterol (2012) 0.92
Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. J Am Coll Surg (2014) 0.91
Hepatectomy for huge hepatocellular carcinoma: single institute's experience. World J Surg (2013) 0.91
Hepatectomy as treatment of choice for hepatocellular carcinoma in elderly cirrhotic patients. World J Surg (2005) 0.90
Portal vein embolization for hepatocellular carcinoma. Liver Cancer (2012) 0.90
Multi-disciplinary treatment for cholangiocellular carcinoma. World J Gastroenterol (2007) 0.89
Reactivation of viral replication after liver resection in patients infected with hepatitis B virus. Ann Surg (2001) 0.89
Preoperative portal vein embolization using an amplatzer vascular plug. Eur Radiol (2008) 0.89
Safe hepatectomy selection criteria for hepatocellular carcinoma patients: a validation of 336 consecutive hepatectomies. The BILCHE score. World J Surg (2015) 0.86
Diagnostic and therapeutic management of hepatocellular carcinoma. World J Gastroenterol (2015) 0.85
Sequential transcatheter arterial chemoembolization and portal vein embolization for hepatocellular carcinoma: the university of Tokyo experience. Semin Intervent Radiol (2008) 0.85
Preoperative portal vein embolization for hepatocellular carcinoma: Consensus and controversy. World J Hepatol (2016) 0.84
Safety and effectiveness of left hepatic trisegmentectomy for hilar cholangiocarcinoma. World J Surg (2005) 0.84
Uses and limitations of portal vein embolization for improving perioperative outcomes in hepatocellular carcinoma. Semin Oncol (2010) 0.84
Proteomic analysis of regenerating mouse liver following 50% partial hepatectomy. Proteome Sci (2009) 0.84
Comparison of childhood hepatic malignancies in a hepatitis B hyper-endemic area. World J Gastroenterol (2005) 0.84
A new approach to percutaneous transhepatic portal embolization using ethanolamine oleate iopamidol. J Gastroenterol (2009) 0.84
Expression of transforming growth factor-alpha and -beta in hepatic lobes after hemihepatic portal vein embolization. Dig Dis Sci (2006) 0.83
Pretreatment assessment of hepatocellular cancer: expert consensus conference. HPB (Oxford) (2010) 0.83
Does the placement of a cystic duct tube after a hepatic resection help reduce the incidence of post-operative bile leak? HPB (Oxford) (2012) 0.83
Estimate or calculate? How surgeons rate volumes and surfaces. Langenbecks Arch Surg (2012) 0.82
Safety and efficacy of partial hepatectomy for huge (≥10 cm) hepatocellular carcinoma: a systematic review. Med Sci Monit (2011) 0.82
Summary of the 2010 AHPBA/SSO/SSAT Consensus Conference on HCC. Int J Hepatol (2011) 0.82
Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC. Int J Hepatol (2011) 0.82
Portal vein embolization: rationale, technique, and current application. Semin Intervent Radiol (2012) 0.82
Modified liver-hanging maneuver designed to minimize blood loss during hepatic parenchymal transection in hemihepatectomy. Surg Today (2010) 0.82
One-stage hepatectomy following portal vein embolization for colorectal liver metastasis. World J Surg (2013) 0.82
Complete hepatocellular carcinoma necrosis following sequential porto-arterial embolization. World J Gastroenterol (2008) 0.81
Remnant liver volume-based predictors of postoperative liver dysfunction after hepatectomy: analysis of 625 consecutive patients from a single institution. Int J Clin Oncol (2013) 0.81
Preoperative portal vein embolisation for primary and metastatic liver tumours: volume effects, efficacy, complications and short-term outcome. HPB (Oxford) (2002) 0.81
Accomplishments in 2007 in the management of hepatobiliary cancers. Gastrointest Cancer Res (2008) 0.81
Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension. HPB (Oxford) (2013) 0.81
Update in management of hepatocellular carcinoma in Eastern population. World J Hepatol (2015) 0.81
Deficiency of the oxygen sensor PHD1 augments liver regeneration after partial hepatectomy. Langenbecks Arch Surg (2012) 0.80
Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol (2012) 0.80
Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma. World J Hepatol (2015) 0.80
Treatment for multiple bilobar liver metastases of colorectal cancer. Langenbecks Arch Surg (2005) 0.80
Impact of future remnant liver volume on post-hepatectomy regeneration in non-cirrhotic livers. Front Surg (2014) 0.80
Portal vein embolization and ligation for extended hepatectomy. Indian J Surg Oncol (2014) 0.80
Identification of cofactors influencing hypertrophy of the future liver remnant after portal vein embolization-the effect of collaterals on embolized liver volume. Br J Radiol (2016) 0.80
The Liver Segmental Volume Ratio for Noninvasive Detection of Cirrhosis: Comparison With Established Linear and Volumetric Measures. J Comput Assist Tomogr (2016) 0.79
Is computed tomography volumetric assessment of the liver reliable in patients with cirrhosis? HPB (Oxford) (2013) 0.79
Reductions in post-hepatectomy liver failure and related mortality after implementation of the LiMAx algorithm in preoperative work-up: a single-centre analysis of 1170 hepatectomies of one or more segments. HPB (Oxford) (2015) 0.79
Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma. Semin Intervent Radiol (2008) 0.79
Inferior right hepatic vein-preserving major right hepatectomy for hepatocellular carcinoma in patients with significant fibrosis or cirrhosis. World J Surg (2014) 0.79
Improved liver function after portal vein embolization and an elective right hepatectomy. HPB (Oxford) (2015) 0.79
Three-dimensional volumetry in 107 normal livers reveals clinically relevant inter-segment variation in size. HPB (Oxford) (2013) 0.78
Predictive indices of morbidity and mortality after liver resection. Ann Surg (2006) 0.78
Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score. World J Gastroenterol (2008) 0.78
Correlation between preoperative serum concentration of type IV collagen 7s domain and hepatic failure following resection of hepatocellular carcinoma. Ann Surg (2004) 0.78
CT/99mTc-GSA SPECT fusion images demonstrate functional differences between the liver lobes. World J Gastroenterol (2013) 0.78
Selection criteria for liver resection in patients with hepatocellular carcinoma and chronic liver disease. World J Gastroenterol (2008) 0.78
Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease. Curr Colorectal Cancer Rep (2015) 0.78
Comparison of remnant to total functional liver volume ratio and remnant to standard liver volume ratio as a predictor of postoperative liver function after liver resection. Korean J Hepatobiliary Pancreat Surg (2013) 0.77
Surgical treatment of neuroendocrine liver metastases. Int J Hepatol (2012) 0.77
Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence. Int J Clin Oncol (2012) 0.77
A review of current status of living donor liver transplantation. Hepatobiliary Surg Nutr (2016) 0.77
Surgical options for initially unresectable colorectal liver metastases. HPB Surg (2012) 0.77
Post-Operative Complications in Living Liver Donors: A Single-Center Experience in China. PLoS One (2015) 0.77
A multidisciplinary approach for the treatment of GIST liver metastasis. World J Surg Oncol (2008) 0.76
Percutaneous right portal vein embolization with polyvinyl alcohol particles in gastric cancer metastasis: report of a case. Surg Today (2005) 0.76
Hepatic clearance measured with (99m)Tc-GSA single-photon emission computed tomography to estimate liver fibrosis. World J Gastroenterol (2014) 0.76
Biliary drainage strategy of unresectable malignant hilar strictures by computed tomography volumetry. World J Gastroenterol (2015) 0.76
Predictors of intraoperative blood loss in patients undergoing hepatectomy. Surg Today (2012) 0.75
Ultrasound-guided liver resection: Early experience in a district general hospital. J Ultrasound (2008) 0.75
Impaired liver function attenuates liver regeneration and hypertrophy after portal vein embolization. World J Hepatol (2016) 0.75
Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard. Psychiatry Clin Neurosci (2001) 36.50
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol (2000) 9.85
X-ray structure analysis of a membrane protein complex. Electron density map at 3 A resolution and a model of the chromophores of the photosynthetic reaction center from Rhodopseudomonas viridis. J Mol Biol (1984) 8.85
Laparoscopic cholecystectomy using fine-caliber instruments. Surg Endosc (1998) 6.62
Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J Biol Chem (1986) 6.03
Surgical strategy for spinal metastases. Spine (Phila Pa 1976) (2001) 5.81
The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr (1994) 5.47
Structure of the protein subunits in the photosynthetic reaction centre of Rhodopseudomonas viridis at 3Å resolution. Nature (2012) 5.22
Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. Nature (1988) 5.09
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet (2000) 4.60
Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev (2001) 4.45
Menstrual cycle alters face preference. Nature (1999) 4.18
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery (1990) 3.93
Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury. Mol Cell Neurosci (2000) 3.73
Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group. Oncology (2000) 3.50
Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology (2000) 3.42
Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet (1985) 3.42
Calculation of child and adult standard liver volume for liver transplantation. Hepatology (1995) 3.33
Sequencing of a Clostridium thermocellum gene (cipA) encoding the cellulosomal SL-protein reveals an unusual degree of internal homology. Mol Microbiol (1993) 3.28
Prostaglandin D2 as a mediator of allergic asthma. Science (2000) 3.19
Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res (1993) 3.05
Colorectal tumours and pit pattern. J Clin Pathol (1994) 3.01
Surgery for small liver cancers. Semin Surg Oncol (1993) 3.00
A novel ER alpha-mannosidase-like protein accelerates ER-associated degradation. EMBO Rep (2001) 2.96
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92
Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem (1991) 2.89
Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature (1998) 2.88
Glycosphingolipid-enriched, detergent-insoluble complexes in protein sorting in epithelial cells. Biochemistry (1993) 2.84
Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology (1992) 2.83
Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature (1998) 2.82
The eukaryotic polypeptide chain releasing factor (eRF3/GSPT) carrying the translation termination signal to the 3'-Poly(A) tail of mRNA. Direct association of erf3/GSPT with polyadenylate-binding protein. J Biol Chem (1999) 2.74
Contrast-enhanced ultrasonography during liver surgery. Br J Surg (2004) 2.71
A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol (2000) 2.70
A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med (1991) 2.68
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. J Clin Oncol (1992) 2.58
Functional counterparts of mammalian protein kinases PDK1 and SGK in budding yeast. Curr Biol (1999) 2.56
Light-induced superconductivity in a stripe-ordered cuprate. Science (2011) 2.54
No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg (1999) 2.47
Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother (2001) 2.46
Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery (1994) 2.45
Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol (1997) 2.44
Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem (1999) 2.44
Structural genomics projects in Japan. Nat Struct Biol (2000) 2.40
Dexamethasone in the treatment of acute mountain sickness. N Engl J Med (1989) 2.31
Fluorescent cholangiography illuminating the biliary tree during laparoscopic cholecystectomy. Br J Surg (2010) 2.30
Recurrence of hepatocellular carcinoma after surgery. Br J Surg (1996) 2.27
Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile. Rev Infect Dis (1984) 2.26
Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med (2000) 2.25
Randomized comparison of ultrasonic vs clamp transection of the liver. Arch Surg (2001) 2.25
Are left-sided gallbladders really located on the left side? Ann Surg (1997) 2.24
Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg (1999) 2.24
Left-molar approach improves the laryngeal view in patients with difficult laryngoscopy. Anesthesiology (2000) 2.23
A detailed linkage map of medaka, Oryzias latipes: comparative genomics and genome evolution. Genetics (2000) 2.19
Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother (2001) 2.17
A second regulatory gene, blaR1, encoding a potential penicillin-binding protein required for induction of beta-lactamase in Bacillus licheniformis. J Bacteriol (1987) 2.15
Use of ryanodine for functional removal of the calcium store in smooth muscle cells of the guinea-pig. Biochem Biophys Res Commun (1988) 2.14
Ski7p G protein interacts with the exosome and the Ski complex for 3'-to-5' mRNA decay in yeast. EMBO J (2001) 2.13
Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun (1996) 2.09
Fukuyama-type congenital muscular dystrophy and the Walker-Warburg syndrome. Brain Dev (1993) 2.08
Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma. Blood (1993) 2.07
Rapid detection of Acanthamoeba cysts in frozen sections of corneal scrapings with Fungiflora Y. Br J Ophthalmol (2009) 2.06
Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn (1987) 2.03
Criteria for safe hepatic resection. Am J Surg (1995) 2.03
How should polypoid lesions of the gallbladder be treated in the era of laparoscopic cholecystectomy? Surgery (1995) 2.02
Multiple molecular forms of diarylpropane oxygenase, an H2O2-requiring, lignin-degrading enzyme from Phanerochaete chrysosporium. Arch Biochem Biophys (1985) 2.01
Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature (2001) 2.01
Escherichia coli replication termination protein impedes the action of helicases. Proc Natl Acad Sci U S A (1989) 2.00
Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy (2010) 1.99
Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg (2000) 1.99
Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet (1987) 1.98
Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology (1998) 1.97
Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan. Antimicrob Agents Chemother (2001) 1.95
Closing-opening wedge osteotomy to correct angular kyphotic deformity by a single posterior approach. Spine (Phila Pa 1976) (2001) 1.93
Development of a polymerase chain reaction-based diagnosis of Trichomonas vaginalis. J Clin Microbiol (1992) 1.91
Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci U S A (2000) 1.91
Structure and switching of bacterial flagellar filaments studied by X-ray fiber diffraction. Nat Struct Biol (1998) 1.89
Primary intestinal lymphangiectasia successfully treated with octreotide. J Gastroenterol (2001) 1.87
Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem (2000) 1.86
Carcinoma arising in the wall of congenital bile duct cysts. Cancer (1979) 1.86
Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg (1995) 1.81
Redistribution of phosphatidylethanolamine at the cleavage furrow of dividing cells during cytokinesis. Proc Natl Acad Sci U S A (1996) 1.81
Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer. Br J Cancer (2001) 1.81
Octamer-binding proteins from B or HeLa cells stimulate transcription of the immunoglobulin heavy-chain promoter in vitro. Genes Dev (1988) 1.80
Calcineurin pathway is required for endothelin-1-mediated protection against oxidant stress-induced apoptosis in cardiac myocytes. Circ Res (2001) 1.78
Relation of pancreatic duct hyperplasia to carcinoma. Cancer (1979) 1.78
Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology (1994) 1.76
Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem (1994) 1.76